Compare ST & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ST | BIO |
|---|---|---|
| Founded | 1916 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.9B |
| IPO Year | 2009 | N/A |
| Metric | ST | BIO |
|---|---|---|
| Price | $50.16 | $293.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | $42.91 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 2.4M | 405.9K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $3,704,500,000.00 | N/A |
| Revenue This Year | $6.47 | $2.74 |
| Revenue Next Year | $4.51 | $3.20 |
| P/E Ratio | $89.22 | ★ $9.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.95 | $219.94 |
| 52 Week High | $53.89 | $343.12 |
| Indicator | ST | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 56.29 | 52.60 |
| Support Level | $33.15 | $262.08 |
| Resistance Level | N/A | $314.39 |
| Average True Range (ATR) | 1.69 | 10.37 |
| MACD | -0.05 | 1.65 |
| Stochastic Oscillator | 48.86 | 46.32 |
Sensata Technologies is a global supplier of sensors and electrical protection for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. It also sells electrical protection products, like contactors and relays. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.